Allergan licenses poly(2-3)Glucose™ for the eye
January, 2015. Allergan, Inc. (NYSE: AGN) purchased an exclusive license from TRGel, LLC for poly(2-3)glucose™ in ophthalmic applications.
20Sep
Related Posts
01Aug
Hydrogel films and coatings
poly(2,3)Glucose™ T1-30-F is now available. This hydrogel forms films and coatings that swell but do not dissolve in water.... read more
LEAVE A COMMENT